← Back to News

Nobel-connected startup Shasqi deepens J&J partnership on CAPAC platform

October 5, 2023

San Francisco-based oncology startup, Shasqi, announced an expansion of its research collaboration with Johnson & Johnson Enterprise Innovation. The partnership centers on Shasqi‘s CAPAC platform, which is an abbreviation for Click-Activated Protodrugs Against Cancer. The platform separates tumor-targeting from the actual drug payload with the aim of maximizing potency while minimizing toxic side effects.

Read the full article here

Want to stay up to date on our news? 
Follow us on LinkedIn